Cholangiocarcinoma

Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center

Giovanni Brandi, Michela Venturi, Maria A. Pantaleo, Giorgio Ercolani, L. Fornaro, Nicola Silvestris, Francesco Leone, E. Vasile, Sara Lonardi, Stefano Cereda, Daniele Santini, Giuseppe Aprile

Research output: Contribution to journalArticle

Abstract

In the oncology landscape, cholangiocarcinoma is a challenging disease in terms of both diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis of cholangiocarcinoma should be supported by imaging techniques (US, CT, MRI) and invasive investigations (ERC or EUS with brushing and FNA or US or CT-guided biopsy) followed by pathological confirmation. Surgery is the main curative option, so resectability of the tumour should be promptly assessed. Moreover, jaundice must be evaluated at the outset because biliary tract decompression with drainage and stent placement may be required. If the patient is resectable, pre-operative assessment of postoperative liver function is mandatory. After a curative resection, an adjuvant therapy may be administered. Otherwise, in cases with macroscopic residual disease after surgery or locally recurrent or unresectable cholangiocarcinoma at the diagnosis, first-line chemotherapy is the preferred strategy, possibly associated with radiotherapy and/or locoregional treatments. As the diagnostic and therapeutic pathway for cholangiocarcinoma can be declined in different modalities, patients should be promptly referred to a multidisciplinary team in a tertiary centre, familiar with this rare but lethal disease. Hence, the aim of the present paper is to focus on diagnostic and therapeutic algorithms based on the common guidelines and also on the clinical practice of multispecialist expert groups.

Original languageEnglish
Pages (from-to)231-241
Number of pages11
JournalDigestive and Liver Disease
Volume48
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Cholangiocarcinoma
Referral and Consultation
Therapeutics
Biliary Tract
Rare Diseases
Decompression
Jaundice
Stents
Drainage
Radiotherapy
Guidelines
Biopsy
Drug Therapy
Liver
Neoplasms

Keywords

  • Biliary tract cancer
  • Diagnosis
  • Therapy

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Cholangiocarcinoma : Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center. / Brandi, Giovanni; Venturi, Michela; Pantaleo, Maria A.; Ercolani, Giorgio; Fornaro, L.; Silvestris, Nicola; Leone, Francesco; Vasile, E.; Lonardi, Sara; Cereda, Stefano; Santini, Daniele; Aprile, Giuseppe.

In: Digestive and Liver Disease, Vol. 48, No. 3, 01.03.2016, p. 231-241.

Research output: Contribution to journalArticle

Brandi, Giovanni ; Venturi, Michela ; Pantaleo, Maria A. ; Ercolani, Giorgio ; Fornaro, L. ; Silvestris, Nicola ; Leone, Francesco ; Vasile, E. ; Lonardi, Sara ; Cereda, Stefano ; Santini, Daniele ; Aprile, Giuseppe. / Cholangiocarcinoma : Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center. In: Digestive and Liver Disease. 2016 ; Vol. 48, No. 3. pp. 231-241.
@article{d56b7f48b7494d78a27f6d07d100a863,
title = "Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center",
abstract = "In the oncology landscape, cholangiocarcinoma is a challenging disease in terms of both diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis of cholangiocarcinoma should be supported by imaging techniques (US, CT, MRI) and invasive investigations (ERC or EUS with brushing and FNA or US or CT-guided biopsy) followed by pathological confirmation. Surgery is the main curative option, so resectability of the tumour should be promptly assessed. Moreover, jaundice must be evaluated at the outset because biliary tract decompression with drainage and stent placement may be required. If the patient is resectable, pre-operative assessment of postoperative liver function is mandatory. After a curative resection, an adjuvant therapy may be administered. Otherwise, in cases with macroscopic residual disease after surgery or locally recurrent or unresectable cholangiocarcinoma at the diagnosis, first-line chemotherapy is the preferred strategy, possibly associated with radiotherapy and/or locoregional treatments. As the diagnostic and therapeutic pathway for cholangiocarcinoma can be declined in different modalities, patients should be promptly referred to a multidisciplinary team in a tertiary centre, familiar with this rare but lethal disease. Hence, the aim of the present paper is to focus on diagnostic and therapeutic algorithms based on the common guidelines and also on the clinical practice of multispecialist expert groups.",
keywords = "Biliary tract cancer, Diagnosis, Therapy",
author = "Giovanni Brandi and Michela Venturi and Pantaleo, {Maria A.} and Giorgio Ercolani and L. Fornaro and Nicola Silvestris and Francesco Leone and E. Vasile and Sara Lonardi and Stefano Cereda and Daniele Santini and Giuseppe Aprile",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.dld.2015.11.017",
language = "English",
volume = "48",
pages = "231--241",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "3",

}

TY - JOUR

T1 - Cholangiocarcinoma

T2 - Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center

AU - Brandi, Giovanni

AU - Venturi, Michela

AU - Pantaleo, Maria A.

AU - Ercolani, Giorgio

AU - Fornaro, L.

AU - Silvestris, Nicola

AU - Leone, Francesco

AU - Vasile, E.

AU - Lonardi, Sara

AU - Cereda, Stefano

AU - Santini, Daniele

AU - Aprile, Giuseppe

PY - 2016/3/1

Y1 - 2016/3/1

N2 - In the oncology landscape, cholangiocarcinoma is a challenging disease in terms of both diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis of cholangiocarcinoma should be supported by imaging techniques (US, CT, MRI) and invasive investigations (ERC or EUS with brushing and FNA or US or CT-guided biopsy) followed by pathological confirmation. Surgery is the main curative option, so resectability of the tumour should be promptly assessed. Moreover, jaundice must be evaluated at the outset because biliary tract decompression with drainage and stent placement may be required. If the patient is resectable, pre-operative assessment of postoperative liver function is mandatory. After a curative resection, an adjuvant therapy may be administered. Otherwise, in cases with macroscopic residual disease after surgery or locally recurrent or unresectable cholangiocarcinoma at the diagnosis, first-line chemotherapy is the preferred strategy, possibly associated with radiotherapy and/or locoregional treatments. As the diagnostic and therapeutic pathway for cholangiocarcinoma can be declined in different modalities, patients should be promptly referred to a multidisciplinary team in a tertiary centre, familiar with this rare but lethal disease. Hence, the aim of the present paper is to focus on diagnostic and therapeutic algorithms based on the common guidelines and also on the clinical practice of multispecialist expert groups.

AB - In the oncology landscape, cholangiocarcinoma is a challenging disease in terms of both diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis of cholangiocarcinoma should be supported by imaging techniques (US, CT, MRI) and invasive investigations (ERC or EUS with brushing and FNA or US or CT-guided biopsy) followed by pathological confirmation. Surgery is the main curative option, so resectability of the tumour should be promptly assessed. Moreover, jaundice must be evaluated at the outset because biliary tract decompression with drainage and stent placement may be required. If the patient is resectable, pre-operative assessment of postoperative liver function is mandatory. After a curative resection, an adjuvant therapy may be administered. Otherwise, in cases with macroscopic residual disease after surgery or locally recurrent or unresectable cholangiocarcinoma at the diagnosis, first-line chemotherapy is the preferred strategy, possibly associated with radiotherapy and/or locoregional treatments. As the diagnostic and therapeutic pathway for cholangiocarcinoma can be declined in different modalities, patients should be promptly referred to a multidisciplinary team in a tertiary centre, familiar with this rare but lethal disease. Hence, the aim of the present paper is to focus on diagnostic and therapeutic algorithms based on the common guidelines and also on the clinical practice of multispecialist expert groups.

KW - Biliary tract cancer

KW - Diagnosis

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84960811277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960811277&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2015.11.017

DO - 10.1016/j.dld.2015.11.017

M3 - Article

VL - 48

SP - 231

EP - 241

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 3

ER -